Significance of disorders of proteomic profile of follicular fluid for predicting the effectiveness of in vitro fertilisation in women with infertility

Abstract

Aim. To study the proteomic profile of follicular fluid in patients with infertility in assisted reproductive technology programs.

Methods. The study included women with infertility included in assisted reproductive technology programs: 15 women who had in vitro fertilisation which resulted in pregnancy (group 1) and 16 women with a negative result of this program (group 2). Fractionation of the follicular fluid samples was performed using the sets of special magnetic beads. Proteomic profiling was performed by tandem MALDI-mass-spectrometry. The anti-Müllerian hormone level was measured by ELISA.

Results. The study revealed differences in the detectability of follicular fluid proteins with different regulatory properties in patients of groups 1 and 2. With the negative outcome of in vitro fertilisation, expression of a number of proteins involved in the processes of folliculogenesis, ovulation, selection of the dominant follicle, as well as proteins necessary for the development of the zygote and blastula was reduced in females' follicular fluid. Increased expression in women from group 2 was registered for proteins enhancing proteolytic reactions, cell apoptosis, including oocytes, which disrupt the positive action of activin and damage structural and functional state of mitochondria. A definite relationship was found between the level of anti-Müllerian hormone and rate of detection of a number of proteins, in particular protocadherin-2α, cystatin C, betaglycan, prostatic acid phosphatase, and dermicidin.

Conclusion. The revealed changes in proteomic profile of the follicular fluid obviously play an important role in the molecular mechanisms that determine the effectiveness of assisted reproductive technologies; the identified differentially expressed proteins can serve as objective markers for predicting the outcomes of in vitro fertilisation.

Keywords

IVF / proteomic analysis / follicular fluid / differentially expressed proteins

References

[1] Paskar' S.S., Kalugina A.S. Perspectives and opportunities of prognostic models use in infertility treatment (a review). Problemy reproduktsii. 2017; 23 (3): 8–11. (In Russ.)

[2] Паскарь С.С., Калугина А.С. Возможности и перспективы применения прогностических моделей в лечении бесплодия (обзор литературы). Пробл. репродукции. 2017; 23 (3): 8-11. DOI: 10.17116/repro20172338-11.

[3] Nazarenko T.A., Mamedova N.R., Monakhova I.V. et al. The choosing of gonadotropins for ovary stimulation in IVF programs. Problemy reproduktsii. 2012; 18 (3): 45–49. (In Russ.)

[4] Назаренко Т.А., Мамедова Н.Р., Монахова И.В. и др. Принципы выбора препаратов для стимуляции яичников у пациенток программ ЭКО. Пробл. репродукции. 2012; 18 (3): 45-49.

[5] Voytashevskiy K.V., Simonovskaya Kh.Yu., Rudneva O.D. et al. Ovarial'nyy rezerv i fertil'nost': slozhnosti XXI veka. Ratsional'nyy podkhod k sokhraneniyu reproduktivnogo rezerva kak zalog fertil'nosti i osoznannogo detorozhdeniya. (Ovarian reserve and fertility: difficulties of 21st century. Rational approach to reproductive reserve maintenance as the pledge of fertility and conscious reproduction.) Moscow: Status Praesens. 2015; 24 p. (In Russ.)

[6] Войташевский К.В., Симоновская Х.Ю., Руднева О.Д. и др. Овариальный резерв и фертильность: сложности XXI века. Рациональный подход к сохранению репродуктивного резерва как залог фертильности и осознанного деторождения. М.: Status Praesens. 2015; 24 c.

[7] Krasnoshoka О.Е., Smol'nikova V.Yu., Kalinina E.A., Elagin V.V. The role of morphological evaluation of oocyte and embryo quality in ART programs (a review). Problemy reproduktsii. 2015; 21 (1): 54–58. (In Russ.)

[8] Красношока О.Е., Смольникова В.Ю., Калинина Е.А., Елагин В.В. Роль морфологической оценки овоцита и эмбриона при использовании вспомогательных репродуктивных технологий (обзор литературы). Пробл. репродукции. 2015; 21 (1): 54-58. DOI: 10.17116/repro20152154-58.

[9] Petrov I.A., Dmitrieva M.L., Tikhonovskaya O.A. et al. The tissue and molecular basis of folliculogenesis. The aging ovaries. Problemy reproduktsii. 2017; 23 (4): 18–23. (In Russ.)

[10] Петров И.А., Дмитриева М.Л., Тихоновская О.А. и др. Тканевые и молекулярные основы фолликулогенеза. Старение яичников. Пробл. репродукции. 2017; 23 (4): 18-23. DOI: 10.17116/repro201723418-23.

[11] Andreeva E.A., Khonina N.A., Pasman N.M. et al. Сytokins in the regulation of ovarian folliculogenesis (a review). Problemy reproduktsii. 2017; 23 (1): 8–14. (In Russ.)

[12] Андреева Е.А., Хонина Н.А., Пасман Н.М. и др. Цитокины в регуляции овариального фолликулогенеза (обзор литературы). Пробл. репродукции. 2017; 23 (1): 8-14. DOI: 10.17116/repro20172318-14.

[13] Markina L.A., Zorina R.M., Zorina V.N. Proteins, cytokines and antigen-specific immunocomplexes of follicular fluid and blood serum in women in in vitro fertilisation. Voprosy akusherstva, ginekologii i perinatologii. 2008; 7 (5): 29–32. (In Russ.)

[14] Маркина Л.А., Зорина Р.М., Зорина В.Н. Белки, цитокины и антигенспецифические иммунокомплексы фолликулярной жидкости и сыворотки крови у женщин при экстракорпоральном оплодотворении. Вопр. акушерства, гинекол. и перинатол. 2008; 7 (5): 29-32.

[15] Gerilovich L.A., Salmina A.B., Egorova A.T. et al. The role of angiogenesis markers in assisted reproductive technology programs in patients with different forms of infertility. Problemy reproduktsii. 2013; (5): 60–63. (In Russ.)

[16] Герилович Л.А., Салмина А.Б., Егорова А.Т. и др. Роль маркёров ангиогенеза у пациенток с различными формами бесплодия в программах вспомогательных репродуктивных технологий. Пробл. репродукции. 2013; (5): 60-63.

[17] Govorun V.M., Ivanov V.T. Proteomics and peptidomics in fundamental and applied medical studies. Bioorganicheskaya khimiya. 2011; (2): 199–215. (In Russ.)

[18] Говорун В.М., Иванов В.Т. Протеомика и пептидомика в фундаментальных и прикладных медицинских исследованиях. Биоорганич. химия. 2011; (2): 199-215.

[19] Baston-Buest D.M., Schanz A., Buest S. et al. The embryo's cystatin C and F expression functions as a protective mechanism against the maternal proteinase cathepsin S in mice. Reproduction. 2010; 139 (4): 741–748. DOI: 10.1530/REP-09-0381.

[20] Baston-Buest D.M., Schanz A., Buest S. et al. The embryo's cystatin C and F expression functions as a protective mechanism against the maternal proteinase cathepsin S in mice. Reproduction. 2010; 139 (4): 741-748. DOI: 10.1530/REP-09-0381.

[21] Robker R.L., Russell D.L., Espey L.L. et al. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc. Natl. Acad. Sci. USA. 2000; 97 (9): 4689–4694. DOI: 10.1073/pnas.080073497.

[22] Robker R.L., Russell D.L., Espey L.L. et al. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc. Natl. Acad. Sci. USA. 2000; 97 (9): 4689-4694. DOI: 10.1073/pnas.080073497.

[23] Balboula A.Z., Yamanaka K., Sakatani M. et al. Cathepsin B activity has a crucial role in the developmental competence of bovine cumulus-oocyte complexes exposed to heat shock during in vitro maturation. Reproduction. 2013; 146 (4): 407–417. DOI: 10.1530/REP-13-0179.

[24] Balboula A.Z., Yamanaka K., Sakatani M. et al. Cathepsin B activity has a crucial role in the developmental competence of bovine cumulus-oocyte complexes exposed to heat shock during in vitro maturation. Reproduction. 2013; 146 (4): 407-417. DOI: 10.1530/REP-13-0179.

[25] Hayashi S., Takeichi M. Emerging roles of protocadherins: from self-avoidance to enhancement of motility. J. Cell. Sci. 2015; 128 (8): 1455–1464. DOI: 10.1242/jcs.166306.

[26] Hayashi S., Takeichi M. Emerging roles of protocadherins: from self-avoidance to enhancement of motility. J. Cell. Sci. 2015; 128 (8): 1455-1464. DOI: 10.1242/jcs.166306.

[27] Simopoulou M., Nikolopoulou E., Dimakakos A. et al. Cell adhesion molecules and in vitro fertilization. In Vivo. 2014; 28 (5): 683–690. PMID: 25189878.

[28] Simopoulou M., Nikolopoulou E., Dimakakos A. et al. Cell adhesion molecules and in vitro fertilization. In Vivo. 2014; 28 (5): 683-690. PMID: 25189878.

[29] Silva J.R., Figueiredo J.R., van den Hurk R. Involvement of growth hormone (GH) and insulin-like growth factor (IGF) system in ovarian folliculogenesis. Theriogenology. 2009; 71 (8): 1193–1208. DOI: 10.1016/j.theriogenology.2008.12.015.

[30] Silva J.R., Figueiredo J.R., van den Hurk R. Involvement of growth hormone (GH) and insulin-like growth factor (IGF) system in ovarian folliculogenesis. Theriogenology. 2009; 71 (8): 1193-1208. DOI: 10.1016/j.theriogenology.2008.12.015.

[31] Juengel J.L., McNatty K.P. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum. Reprod. Update. 2005; 11 (2): 143–160. DOI: 10.1093/humupd/dmh061.

[32] Juengel J.L., McNatty K.P. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum. Reprod. Update. 2005; 11 (2): 143-160. DOI: 10.1093/humupd/dmh061.

[33] Omori Y., Nakamura K., Yamashita S. et al. Effect of follicle-stimulating hormone and estrogen on the expression of betaglycan messenger ribonucleic acid levels in cultured rat granulosa cells. Endocrinology. 2005; 146 (8): 3379–3386. DOI: 10.1210/en.2004-1665.

[34] Omori Y., Nakamura K., Yamashita S. et al. Effect of follicle-stimulating hormone and estrogen on the expression of betaglycan messenger ribonucleic acid levels in cultured rat granulosa cells. Endocrinology. 2005; 146 (8): 3379-3386. DOI: 10.1210/en.2004-1665.

[35] Doyle K.M., Russell D.L., Sriraman V., Richards J.S. Coordinate transcription of the ADAMTS-1 gene by luteinizing hormone and progesterone receptor. Mol. Endocrinol. 2004; 18 (10): 2463–2478. DOI: 10.1210/me.2003-0380.

[36] Doyle K.M., Russell D.L., Sriraman V., Richards J.S. Coordinate transcription of the ADAMTS-1 gene by luteinizing hormone and progesterone receptor. Mol. Endocrinol. 2004; 18 (10): 2463-2478. DOI: 10.1210/me.2003-0380.

[37] Yung Y., Maman E., Konopnicki S. et al. ADAMTS-1: a new human ovulatory gene and a cumulus marker for fertilization capacity. Mol. Cell. Endocrinol. 2010; 328 (1–2): 104–108. DOI: 10.1016/j.mce.2010.07.019.

[38] Yung Y., Maman E., Konopnicki S. et al. ADAMTS-1: a new human ovulatory gene and a cumulus marker for fertilization capacity. Mol. Cell. Endocrinol. 2010; 328 (1-2): 104-108. DOI: 10.1016/j.mce.2010.07.019.

[39] Herr D., Bekes I., Wulff C. Local renin-angiotensin system in the reproductive system. Front. Endocrinol. (Lausanne). 2013; 4: 150. DOI: 10.3389/fendo.2013.00150.

[40] Portela V.M., Zamberlam G., Gonçalves P.B. et al. Role of angiotensin II in the periovulatory epidermal growth factor-like cascade in bovine granulosa cells in vitro. Biol. Reprod. 2011; 85 (6): 1167–1174. DOI: 10.1095/biolreprod.111.094193.

[41] Portela V.M., Zamberlam G., Gonçalves P.B. et al. Role of angiotensin II in the periovulatory epidermal growth factor-like cascade in bovine granulosa cells in vitro. Biol. Reprod. 2011; 85 (6): 1167-1174. DOI: 10.1095/biolreprod.111.094193.

[42] Palumbo A., Ávila J., Naftolin F. The Ovarian Renin-Angiotensin System (OVRAS): A major factor in ovarian function and disease. Reprod. Sci. 2016; 23 (12): 1644–1655.

[43] Palumbo A., Ávila J., Naftolin F. The Ovarian Renin-Angiotensin System (OVRAS): A major factor in ovarian function and disease. Reprod. Sci. 2016; 23 (12): 1644-1655.

[44] Colombe S., Houllier L., Fleurot E. et al. Syndecan 1 represses cell growth and FSH responsiveness in human granulosa cells. Reproduction. 2017; 153 (6): 797–808. DOI: 10.1530/REP-17-0074.

[45] Colombe S., Houllier L., Fleurot E. et al. Syndecan 1 represses cell growth and FSH responsiveness in human granulosa cells. Reproduction. 2017; 153 (6): 797-808. DOI: 10.1530/REP-17-0074.

[46] Wang L.Y., Wang D.H., Zou X.Y., Xu C.M. Mitochondrial functions on oocytes and preimplantation embryos. J. Zhejiang Univ. Sci. B. 2009; 10 (7): 483–492. DOI: 10.1631/jzus.B0820379.

[47] Wang L.Y., Wang D.H., Zou X.Y., Xu C.M. Mitochondrial functions on oocytes and preimplantation embryos. J. Zhejiang Univ. Sci. B. 2009; 10 (7): 483-492. DOI: 10.1631/jzus.B0820379.

[48] Schatten H., Sun Q.Y., Prather R. The impact of mitochondrial function/dysfunction on IVF and new treatment possibilities for infertility. Reprod. Biol. Endocrinol. 2014; 12: 111. DOI: 10.1186/1477-7827-12-111.

[49] Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil. Steril. 2012; 98 (3): 591–598. DOI: 10.1016/j.fertnstert.2012.05.031.

[50] Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil. Steril. 2012; 98 (3): 591-598. DOI: 10.1016/j.fertnstert.2012.05.031.

[51] Rustamov O., Smith A., Roberts S.A. et al. Anti-Mullerian hormone: poor assay reproducibility in a largе cohort of subjects suggests sample instability. Hum. Reprod. 2012; 27: 3085–3091. DOI: 10.1093/humrep/des260.

[52] Rustamov O., Smith A., Roberts S.A. et al. Anti-Mullerian hormone: poor assay reproducibility in a largе cohort of subjects suggests sample instability. Hum. Reprod. 2012; 27: 3085-3091. DOI: 10.1093/humrep/des260.

[53] Kevenaar M.E., Themmen A.P., Laven J.S. et al. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Hum. Reprod. 2007; 22 (6): 1547–1554. DOI: 10.1093/humrep/dem036.

[54] Kevenaar M.E., Themmen A.P., Laven J.S. et al. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Hum. Reprod. 2007; 22 (6): 1547-1554. DOI: 10.1093/humrep/dem036.

[55] Dólleman M., Verschuren W.M., Eijkemans M.J. et al. Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study. J. Clin. Endocrinol. Metabol. 2013; 98 (5): 2106–2115. DOI: 10.1210/jc.2012-3995.

[56] Dólleman M., Verschuren W.M., Eijkemans M.J. et al. Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study. J. Clin. Endocrinol. Metabol. 2013; 98 (5): 2106-2115. DOI: 10.1210/jc.2012-3995.

RIGHTS & PERMISSIONS

Zolotykh O.S., Lomteva S.V., Sagamonova K.Y.